Invention Grant
- Patent Title: Galactose oxidase treatment of dendritic cells to improve their immunogenicity
-
Application No.: US15106082Application Date: 2014-12-18
-
Publication No.: US10253294B2Publication Date: 2019-04-09
- Inventor: Marion Heuer , Manfred Lutz , Andreas Beilhack
- Applicant: Julius-Maximilians-Universität Würzburg
- Applicant Address: DE Würzburg
- Assignee: JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
- Current Assignee: JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
- Current Assignee Address: DE Würzburg
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP13198153 20131218
- International Application: PCT/EP2014/078447 WO 20141218
- International Announcement: WO2015/091787 WO 20150625
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/02 ; C12N5/0784 ; A61K39/00
Abstract:
The present invention relates to a method for producing dendritic cells with increased capability to activate T cells, to dendritic cells obtainable by such a method, and to a pharmaceutical composition comprising such dendritic cells.
Public/Granted literature
- US20160312184A1 Galactose Oxidase Treatment of Dendritic Cells to Improve their Immunogenicity Public/Granted day:2016-10-27
Information query
